Carbon emissions

Female researcher in a laboratory
#Antibiotic resistance #Antibiotics #Antibody-based therapeutics #Antimicrobial resistance (AMR) #Cancer research #Carbon emissions #Environmental impact #Green lab movement #Immunotherapy #Interview #Lab technology #Molecular Biology #Oncology #Sustain #T cell activation

New podcast: Strategies and challenges in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Strategies and challenges in therapeutic development and lab practice”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The inner workings of antibiotics”, “Targeting advances in immunotherapies”, and… Read More

#News

#Biopharma #Carbon emissions #Environmental impact #Sustainability

Survey reveals biopharma sustainability lacks momentum

In the Global Biopharma Sustainability Review by Cytiva, more than 800 pharma and biopharma professionals articulated the benefits of meeting sustainability targets – and the risks of not clearly measuring progress on those targets. The research includes insights from executives in 18 countries. Sustainability is rising… Read More

#News

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

#Carbon emissions #Environmental impact #Green lab movement #Interview #Lab technology #Sustain

The considerations for building sustainable labs in pharma

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Will Fogden, UK Development Manager, Kadans Science Partner, about sustainable efforts in pharma and the considerations industry needs to take into account when developing sustainable buildings. RA: We’ve seen large-scale sustainability efforts from pharma. Is the lab… Read More

#Exclusive Content #Trends & Analysis

Amazon Rainforest
#AstraZeneca #Carbon emissions #Environmental #Environmental impact #Sustainability

AZ to invest $400 million in reforestation and biodiversity

AstraZeneca has announced a $400 million investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the company’s climate action, restore nature,… Read More

#News

#Carbon emissions #Climate change #Comment #Life sciences #Pharma

Pharma’s important climate

Listen to this article on the DDW podcast: By DDW Editor Reece Armstrong The looming threat of global warming, consequences of which can already be seen and felt across the planet, will impact us all. It seems that despite a constant barrage of warnings by scientists and experts, alongside visible effects… Read More

#Exclusive Content #Opinion

#Cancer #Cancer research #Carbon emissions #Covid-19 #Drug development #Drug discovery #Graft vs Host Disease #Monkeypox #Sustainability

Latest industry updates for the DDW Highlights series

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week we learned the shocking statistic that… Read More

#News

#Cancer #Cancer research #Carbon emissions #Covid-19 #Drug development #Drug discovery #Graft vs Host Disease #Monkeypox #Sustainability

This week in drug discovery (7-11 November)

News round-up for 7-11 November by DDW Digital Content Editor Diana Spencer  This week we learned the shocking statistic that a third of scientific researchers have, or know a close colleague who has, experienced abuse after posting research online.  It wasn’t all bad news, however, as top… Read More

#News